Compound ID | 2074
Class: Antibacterial sulfonamide (sulfa drug)
Spectrum of activity: | Gram-positive & Gram-negative |
Details of activity: | Sulphonamides are structural analogues of p-aminobenzoic acid and act as competitive inhibitors (and alternate substrates) of dihydropteroate synthase (DHPS) to block the synthesis of folic acid. Primarily bacteriostatic; rapid emergence of resistance. |
Description: | Synthetic sufanilamide derivative; short-acting (4-8 hours). Oral and topical application. |
Year first mentioned: | 1942 |
Development status: | Discontinued |
Chemical structure(s): | |
Canonical SMILES: | C1=C(C=CC(=C1)S(=O)(=O)NC2=NC=CS2)N |
Isomeric SMILES: | C1=CC(=CC=C1N)S(=O)(=O)NC2=NC=CS2 |
InChI: | InChI=1S/C9H9N3O2S2/c10-7-1-3-8(4-2-7)16(13,14)12-9-11-5-6-15-9/h1-6H,10H2,(H,11,12) |
InChI Key: | JNMRHUJNCSQMMB-UHFFFAOYSA-N |
Structure link: | https://pubchem.ncbi.nlm.nih.gov/compound/5340 |
External links: | |
Guide to Pharmacology: | sulfathiazole |
Main Source: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2601063/pdf/yjbm00510-0025.pdf |
Citation: | https://pubmed.ncbi.nlm.nih.gov/25455640/ |